Insmed | INSM - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 -0.61 -1.75 Oct/22
FY2026Q2 Jun/2026 -0.75 -1.70 Jul/30
FY2026Q1 Mar/2026 -0.76 -0.99 -1.42 May/07
FY2025Q4 Dec/2025 -1.54 -1.28 -1.32 Feb/19
FY2025Q3 Sep/2025 -1.75 -1.34 -1.27 Oct/30




Eps Alterar Data
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Cytokinetics USD -1.67 0.17 2026-03
DBV Technologies USD -0.55 0.31 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -0.76 0.78 2026-03
Novartis USD 1.99 0.45 2026-03
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03